Rajagopalan, Sanjay <br/><br/>
Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease.  [electronic resource] 

 -  Human gene therapy  Jun 2004 
 - 619-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1043-0342 
<br/><br/><label>Standard No.: </label>10.1089/104303404323142060  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Calcium-Binding Proteins<br/>Carrier Proteins--therapeutic use<br/>Cell Adhesion Molecules<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Gene Transfer Techniques<br/>Genetic Therapy<br/>Genetic Vectors<br/>Humans<br/>Intercellular Signaling Peptides and Proteins<br/>Intermittent Claudication--etiology<br/>Male<br/>Middle Aged<br/>Neovascularization, Pathologic<br/>Peripheral Vascular Diseases--complications<br/>Placebos